Self-inflicted DNA damage drives cancer cell resistance to radiation therapy
Commonly used radiation therapy kills cancer cells by inflicting extensive DNA damage to the irradiated tissue. Naturally occurring DNA damage in human cells is efficiently remedied by a large number of DNA repair pathways. Yet this process takes time, and the addiction of cancer cells to rapid uncontrolled cell division renders them incapable of dealing with the level of DNA damage inflicted by high doses of radiation. As a result, radiation therapy efficiently kills tumor cells. Despite the success of the method, reoccurrence of tumors is still common. The mechanisms through which tumor cells manage to evade cell death after lethal doses of irradiation are not well understood, and hence resistance to RT remains a considerable challenge for effective clinical tumor control.
An international team including researcher from our group at the Department of Medical Biochemistry and Biophysics, Division of Genome Biology, Karolinska Institutet now shed light into an unexpected strategy of cancer cells to evade death by radiation in a study published in Science. The team of scientists working in Denmark, Sweden, Canada and Switzerland, coordinated by Claus Storgaard Sørensen at the Biotech Research & Innovation Centre (BRIC), University of Copenhagen, found that in response to radiation, tumor cells can activate an endogenous nuclease, CAD, which initiates genome-wide DNA breaks. While persistent DNA damage is generally bad news for the cell, the self-inflicted DNA breaks made in this context helps cancer cells to suspend their program to divide, pausing their cell cycle at the so-called G2 checkpoint, and gain time to repair the remaining DNA damage.
Using a method to map the ‘nicks’ – single-strand DNA breaks – introduced by activation of CAD in response to radiation, researchers at SciLifeLab then found that self-inflicted DNA damage was non-random and instead concentrated on a small number of regions in the genome. What’s more, the authors found that this phenomenon was specific for cancer cells as loss of CAD activity rendered cancer cells, but not normal cells, vulnerable to radiation-induced damage.
“With CAD-inflicted DNA damage following a discernable pattern, we hope to investigate in the future how the cell targets and contains this potent endogenous nuclease activity.” says Philip Yuk Kwong Yung, postdoctoral fellow in our lab.
Collectively, the findings highlight a cancer-specific survival mechanism that could be targeted and exploited to enhance the tumor cells’ vulnerability to genotoxic cancer treatments. Indeed, the study also showed that experimental blocking of the CAD function made tumor cells (but not normal healthy cells) more sensitive to radiation, thereby suggesting how this new knowledge could be used to improve the outcome of radiotherapy in the future.
Our research was funded by Vetenskapsrådet and ERC.